Neurohormonal activation in acute heart failure: Results from VERITAS

Cardiology

Volumn 119, Issue 2, 2011, Pages 96-105

  Milo Cotter, Olga ^a   Cotter Davison, Beth ^a   Lombardi, Carlo ^d   Sun, Hengrui ^a   Bettari, Luca ^d   Bugatti, Silvia ^d   Rund, Michele ^a   Metra, Marco ^d   Kaluski, Edo ^b   Kobrin, Isaac ^e   Frey, Aline ^e   Rainisio, Maurizio ^f   McMurray, John J V ^g   Teerlink, John R ^c   Cotter Davison, Gad ^a  

^a Momentum Research Inc   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e Abanovus LLC   (Italy)

^f University of Glasgow ^*

^g UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Heart failure; Inflammation; Prognosis

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; INTERLEUKIN 6; NATRIURETIC PEPTIDE RECEPTOR B; NEUROHORMONE; NORADRENALIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TEZOSENTAN; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I; TROPONIN T; VON WILLEBRAND FACTOR;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEART FAILURE; HUMANS; IMMUNOASSAY; INTERLEUKIN-6; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I; VON WILLEBRAND FACTOR;

EID: 80052571307     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000330409     Document Type: Article

References (33)

1. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
2. Harinstein ME, Filippatos GS, Gheorghiade M: Acute heart failure syndromes: Epidemiology, risk stratification and prognostic factors. Acute Card Care 2009; 11: 77-82.
3. Gheorghiade M, Pang PS: Acute heart failure syndromes. J Am Coll Cardiol 2009; 53: 557-573.
4. Cotter G, Felker GM, Adams KF, Milo-Cotter O, O'Connor CM: The pathophysiology of acute heart failure -is it all about fluid accumulation? Am Heart J 2008; 155: 9-18. (Pubitemid 350234787)
5. Tsutamoto T, Wada A, Hayashi M, Tsutsui T, Maeda K, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Ishii C, Kinoshita M: Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J 2003; 24: 346-355. (Pubitemid 36215968)
6. Biasucci LM, Liuzzo G, Colizzi C, Rizzello V: Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. Ital Heart J 2001; 2: 164-171. (Pubitemid 32409862)
7. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-1206. (Pubitemid 26117714)
8. Mann DL, Young JB: Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904. (Pubitemid 24088479)
9. Blum A, Miller H: Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 2001; 52: 15-27. (Pubitemid 32195312)
10. Kjaer A, Hesse B: Heart failure and neuroendocrine activation: Diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21: 661-672. (Pubitemid 33120896)
11. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241. (Pubitemid 20225044)
12. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST). Circulation 2001; 103: 2055-2059. (Pubitemid 32373007)
13. Zhao SP, Zeng LH: Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int J Cardiol 1997; 58: 257-261.
14. Bozkurt B, Mann DL, Deswal A: Biomarkers of inflammation in heart failure. Heart Fail Rev 2010; 15: 331-341.
15. Tsutamoto T, Asai S, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Ohnishi M, Wada A, Saito Y, Horie M: Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail 2007; 9: 1032-1037. (Pubitemid 47451817)
16. Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T: Timecourse of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 2005; 100: 415-420.
17. Chin BS, Conway DS, Chung NA, Blann AD, Gibbs CR, Lip GY: Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: Relationship to treatment and prognosis. Blood Coagul Fibrinolysis 2003; 14: 515-521. (Pubitemid 37083165)
18. Matsumoto M, Tsujino T, Lee-Kawabata M, Naito Y, Sakoda T, Ohyanagi M, Masuyama T: Serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction. Cytokine 2010; 49: 264-268.
19. Milo O, Cotter G, Kaluski E, Brill A, Blatt A, Krakover R, Vered Z, Hershkoviz R: Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 2003; 92: 222-226. (Pubitemid 36835978)
20. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G: Cytokines and acute heart failure. Crit Care Med 2008; 36(1 suppl):S9-S16.
21. Braunwald E: Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159.
22. Teerlink JR: Endothelins: Pathophysiology and treatment implications in chronic heart failure. Curr Heart Fail Rep 2005; 2: 191-197.
23. Masson S, Latini R, Anand IS, Barlera S, Judd D, Salio M, Perticone F, Perini G, Tognoni G, Cohn JN; Val-HeFT investigators: The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 2006; 12: 375-380. (Pubitemid 43833416)
24. Spieker LE, Noll G, Ruschitzka FT, Lüscher TF: Endothelin receptor antagonists in congestive heart failure: A new therapeutic principle for the future? J Am Coll Cardiol 2001; 37: 1493-1505.
25. Moe GW, Howlett J, Januzzi JL, Zowall H; Canadian Multicenter Improved Management of Patients with Congestive Heart Failure (IMPROVE-CHF) Study Investigators: N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: Primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 2007; 115: 3103-3110. (Pubitemid 46956499)
26. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators: Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 1943-1950. (Pubitemid 46694287)
27. Peacock WFIV, De Marco T, Fonarow GC, et al: Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008; 358: 2117-2126. (Pubitemid 351679598)
28. Gattis WA, O'Connor CM, Hasselblad V, Adams KF, Kobrin I, Gheorghiade M: Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol 2004; 93: 1436-1437. (Pubitemid 38692482)
29. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN; Val-HeFT Investigators: C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-1434. (Pubitemid 41291768)
30. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB; Framingham Heart Study: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 2003; 107: 1486-1491. (Pubitemid 36378485)
31. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I; VERITAS Investigators: Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA 2007; 298: 2009-2019. (Pubitemid 350074798)
32. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E: Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002; 105: 1760-1763. (Pubitemid 34408881)
33. Miettinen KH, Lassus J, Harjola VP, Siirilä-Waris K, Melin J, Punnonen KR, Nieminen MS, Laakso M, Peuhkurinen KJ: Prognostic role of pro-and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure (abstract 2794). Circulation 2007; 116:II-621.